《盈利預喜》丘鈦科技(01478.HK)料全年溢利大增 最少賺5億人民幣
丘鈦科技(01478.HK)發盈喜,預計今年底止年度將錄得股東應佔溢利介乎5-5.2億人民幣,相對上一年度溢利1,440萬人民幣,增幅即約33.7-35.1倍。原因包括︰攝像頭模組銷售數量明顯增長,且產品結構下半年明顯改善,綜合產品毛利率明顯提升;指紋識別模組銷售數量輕微下跌,但產品結構改善明顯,指紋識別模組綜合產品毛利率明顯提升;生產自動化升級改造漸見成效,人工成本明顯優化;及聯營新鉅科技經營情況明顯改善並錄得盈利。然而,人民幣兌美元匯率受貿易糾紛等影響波動劇烈,影響了集團的經營利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.